Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000340691 | SCV000467501 | uncertain significance | Long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617989 | SCV000737713 | likely benign | Cardiovascular phenotype | 2021-09-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000765942 | SCV000897363 | uncertain significance | Short QT syndrome type 1; Long QT syndrome 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841270 | SCV000914030 | likely benign | Cardiac arrhythmia | 2018-09-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000340691 | SCV001000650 | likely benign | Long QT syndrome | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706593 | SCV004032783 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | KCNH2: BS1 |
Clinical Genetics, |
RCV001706593 | SCV001922597 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001706593 | SCV001953638 | likely benign | not provided | no assertion criteria provided | clinical testing |